Yoichiro Hirata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoichiro Hirata has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Akihito Saito
The University of Tokyo Hospital, Department of Cardiology, Tokyo, Japan
1 shared publicationAkira Oka
The University of Tokyo Hospital, Department of Pediatrics, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1138655, Japan
1 shared publicationAtsushi Kitagawa
Department of Pediatrics, Kitasato University School of Medicine, Sagamihara, Japan
1 shared publicationChie Murata
Department of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, Japan
1 shared publication- Daigo Ochiai
Department of Obstetrics and Gynecology Kitasato University School of Medicine Sagamihara Japan
1 shared publication - Daiju Fukuda
Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences
1 shared publication
Latest Publications
- Open Access
- 17 May 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (8) , 3254-3257
Prenatal aortic arch development in double aortic arch: Understanding postnatal closure of left aortic arch: A case report
- 17 May 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (8) , 3254-3257
Open AccessPrenatal aortic arch development in double aortic arch: Understanding postnatal closure of left aortic arch: A case report
- Open Access
- 4 March 2016
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 2 (3) , e1501332
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
Obesity stimulates chronic inflammation in adipose tissue, which is associated with insulin resistance, although the underlying mechanism remains largely unknown. Here we showed that obesity-related adipocyte degeneration causes release of cell-free DNA (cfDNA), which promotes macrophage accumulation in adipose tissue via Toll-like receptor 9 (TLR9), originally known as a sensor of exogenous DNA fragments. Fat-fed obese wild-type mice showed increased release of cfDNA, as determined by the concentrations of single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) in plasma. cfDNA released from degenerated adipocytes promoted monocyte chemoattractant protein-1 (MCP-1) expression in wild-type macrophages, but not in TLR9-deficient (Tlr9−/−) macrophages. Fat-fed Tlr9−/− mice demonstrated reduced macrophage accumulation and inflammation in adipose tissue and better insulin sensitivity compared with wild-type mice, whereas bone marrow reconstitution with wild-type bone marrow restored the attenuation of insulin resistance observed in fat-fed Tlr9−/− mice. Administration of a TLR9 inhibitory oligonucleotide to fat-fed wild-type mice reduced the accumulation of macrophages in adipose tissue and improved insulin resistance. Furthermore, in humans, plasma ssDNA level was significantly higher in patients with computed tomography–determined visceral obesity and was associated with homeostasis model assessment of insulin resistance (HOMA-IR), which is the index of insulin resistance. Our study may provide a novel mechanism for the development of sterile inflammation in adipose tissue and a potential therapeutic target for insulin resistance.
- 4 March 2016
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 2 (3) , e1501332
Open AccessObesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
Obesity stimulates chronic inflammation in adipose tissue, which is associated with insulin resistance, although the underlying mechanism remains largely unknown. Here we showed that obesity-related adipocyte degeneration causes release of cell-free DNA (cfDNA), which promotes macrophage accumulation in adipose tissue via Toll-like receptor 9 (TLR9), originally known as a sensor of exogenous DNA fragments. Fat-fed obese wild-type mice showed increased release of cfDNA, as determined by the concentrations of single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) in plasma. cfDNA released from degenerated adipocytes promoted monocyte chemoattractant protein-1 (MCP-1) expression in wild-type macrophages, but not in TLR9-deficient (Tlr9−/−) macrophages. Fat-fed Tlr9−/− mice demonstrated reduced macrophage accumulation and inflammation in adipose tissue and better insulin sensitivity compared with wild-type mice, whereas bone marrow reconstitution with wild-type bone marrow restored the attenuation of insulin resistance observed in fat-fed Tlr9−/− mice. Administration of a TLR9 inhibitory oligonucleotide to fat-fed wild-type mice reduced the accumulation of macrophages in adipose tissue and improved insulin resistance. Furthermore, in humans, plasma ssDNA level was significantly higher in patients with computed tomography–determined visceral obesity and was associated with homeostasis model assessment of insulin resistance (HOMA-IR), which is the index of insulin resistance. Our study may provide a novel mechanism for the development of sterile inflammation in adipose tissue and a potential therapeutic target for insulin resistance.